NEW YORK — When the SARS-CoV-2 virus brought the world to a standstill in early 2020, global health researchers possessed a crucial, hard-won advantage: decades of prior academic and clinical research on coronaviruses. Because scientists already understood the fundamental architectures of key viral proteins, they were able to design, test, and manufacture effective vaccines in […]
Headline
Tag: avert
Back To Top